Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery

Patent metadata

Field	Value
Publication number	US-11154684-B2
Application number	US-201815899063-A
Country	US
Kind code	B2
Filing date	Feb 19, 2018
Priority date	May 27, 2009
Publication date	Oct 26, 2021
Grant date	Oct 26, 2021

Abstract

A valve assembly having a housing and a valve, the valve being disposed within the housing, a first indexed member integral to the housing, the first indexed member adapted to be complementary to a second indexed member, and a radio frequency identification device adapted to communicate with a radio frequency receiver, the valve being configured to align with a canister, seal the canister and open in a single movement. A drug containment device having said valve assembly is also disclosed.

First claim

We claim:

1. A drug containment device, comprising:
a canister containing a therapeutic gas;
a housing and a valve operatively coupled with the canister, at least a portion of the valve being disposed within the housing and configured for regulating flow of the therapeutic gas from the canister when actuated along a longitudinal axis of the canister; and
an indexed member integral to the housing and adapted to engage a complementarily indexed member of a gas delivery and regulation apparatus when aligned therewith via a single relative movement that is perpendicular to the longitudinal axis so as to enable the drug containment device to be aligned with and secured to the gas delivery and regulation apparatus in a manner that provides sufficient engagement for actuation of the valve.

2. The drug containment device of claim 1 , wherein the therapeutic gas comprises an active pharmaceutical ingredient and an inactive carrier gas.

3. The drug containment device of claim 2 , wherein the inactive carrier gas comprises at least one of N 2 and O 2 , and wherein the active pharmaceutical ingredient comprises at least one of (i) nitric oxide, with a concentration in the range of approximately 50 ppm to 10,000 ppm, (ii) carbon monoxide, with a concentration in the range of approximately 500 ppm to 20,000 ppm, and (iii) a chalcogenide compound.

4. The drug containment device of claim 1 , wherein the valve comprises a spring biased needle valve.

5. The drug containment device of claim 1 , wherein the indexed member comprises a first arcuate opening and a second arcuate opening that extend arcuately about, and on at least a portion of opposing sides of, the longitudinal axis of the canister, the first and second arcuate openings having at least one of different axial widths or misaligned mid-planes.

6. The drug containment device of claim 5 , wherein the first arcuate opening is directly opposite from the second arcuate opening.

7. The drug containment device of claim 6 , wherein the first and second arcuate openings have both different axial widths and misaligned mid-planes.

8. The drug containment device of claim 1 , wherein the indexed member is configured to be a support enabling the canister to be suspended vertically.

9. The drug containment device of claim 2 , wherein indexed member is configured to be a support permitting actuation of the valve along the longitudinal axis of the canister.

10. A drug delivery system, comprising:
the drug containment device of claim 1 , and
a therapeutic gas delivery and regulation apparatus, the therapeutic gas delivery and regulation apparatus comprising the complementary indexed member.

11. The drug delivery system of claim 10 , wherein the drug containment device is removable from the therapeutic gas delivery and regulation apparatus via a relative movement that is perpendicular to the longitudinal axis.

12. The drug delivery system of claim 10 , wherein one or both of the indexed member and the complementary indexed member has a respective surface configured as a support enabling the drug containment device to be seated in the drug delivery and regulation device and permitting actuation of the valve along the longitudinal axis of the canister.

13. A drug containment device, comprising:
a canister having a valve configured for regulating flow of a therapeutic gas contained in the canister via actuation of the valve along a longitudinal axis of the canister; and
a housing encasing at least a portion of the valve and having an indexed member adapted to engage a complementarily indexed member of a therapeutic gas delivery and regulation apparatus when aligned therewith via a single relative movement that is perpendicular to the longitudinal axis of the canister to thereby ensure the canister is an authorized canister type, and enable the drug containment device to be aligned with and secured to the therapeutic gas delivery and regulation apparatus in a manner that provides sufficient engagement for actuation of the valve.

14. The drug containment device of claim 13 , wherein the indexed member comprises a first arcuate opening and a second arcuate opening that extend arcuately about, and on at least a portion of opposing sides of, the longitudinal axis of the canister, the first and second arcuate openings having at least one of different axial widths or misaligned mid-planes.

15. The drug containment device of claim 14 , wherein the first arcuate opening is directly opposite from the second arcuate opening, and wherein the first and second arcuate openings have both different axial widths and misaligned mid-planes.

16. The drug containment device of claim 13 , wherein the indexed member is configured to be a support enabling the canister to be suspended vertically and permitting actuation of the valve along the longitudinal axis of the canister.

17. A drug delivery system, comprising:
the drug containment device of claim 13 , and
a therapeutic gas delivery and regulation apparatus, the therapeutic gas delivery and regulation apparatus comprising the complementary indexed member.

18. The therapeutic gas delivery system of claim 17 , wherein the drug containment device is removable from the therapeutic gas delivery and regulation apparatus via a relative movement that is perpendicular to the longitudinal axis.

19. The drug delivery system of claim 17 , wherein one or both of the indexed member and the complementary indexed member has a respective surface configured as a support enabling the drug containment device to be seated in the drug delivery and regulation device and permitting actuation of the valve along the longitudinal axis of the canister.

20. An indexed drug containment device for an indexed drug actuation device for use in an indexed drug delivery and regulation device, the indexed drug containment device comprising:
a valve assembly comprising a housing and a valve, the valve disposed within the housing,
a gas canister in fluid communication with the valve, the canister containing an active pharmaceutical ingredient and an inactive gas carrier, the canister being aligned along a longitudinal axis, the valve being axially actuatable along the longitudinal axis,
a first indexed member integral to the housing and a third indexed member integral to the housing, the first indexed member adapted to be complementary to a second indexed member integral to a collar of the indexed drug actuation device, the second indexed member being a first key, the third indexed member adapted to be complementary to a fourth indexed member integral to the collar of the indexed drug actuation device, the fourth indexed member being a second key, wherein the first indexed member is non-complementary to the fourth indexed member, and wherein the third indexed member is non-complementary to the second indexed member,
wherein the first indexed member is a first opening disposed on one side of the housing and the third indexed member is a second opening disposed on an opposite side of the housing with respect to the longitudinal axis of the gas canister,
wherein the housing is engageable by the collar of the indexed drug actuation device in a direction perpendicular to the longitudinal axis,
wherein one or more of the first and third indexed members are predeterminately adapted to indicate the identity of the active pharmaceutical ingredient, wherein indexing features that correspond to the identity of the active pharmaceutical ingredient are provided by one or more of different axial widths, axial jux

Assignees

• Mallinckrodt Hospital Products Ip Ltd

Inventors

• Montgomery Frederick J
• Bathe Duncan P
• Lee Daniel J
• Biba Scott I
• Bakken Todd J

Classifications

• F17C2260/028

  Avoiding unauthorised transfer · CPC title

• F17C2270/025

  Breathing · CPC title

• F17C2205/0188

  Hanging up devices · CPC title

• F17C2205/0153

  Details of mounting arrangements · CPC title

• F17C13/003

  Means for coding or identifying them and/or their contents · CPC title